fbpx Skip to main content
Category

Ophthalmology

OphthalmologyWet AMD

Wet AMD Pipeline Therapies

Although anti-VEGF therapy has revolutionized care for wet age-related macular degeneration (AMD), real-world analyses have shown limited improvement in visual acuity over time, largely due to treatment burden. However, several pipeline therapies could reduce the…
November 4, 2021
OphthalmologyWet AMD

Genetic Polymorphism and Wet AMD

Anti-VEGF intravitreal injections are used to treat wet age-related macular degeneration (AMD). This meta-analysis, published in Ophthalmic Research, examined the available research on the genetic polymorphism of ARMS2 A69S conferring susceptibility to AMD with response to…
November 4, 2021